Menu

Life Science

The Life Science Commission boosts the topics around pharmaceutical products and their protection by IP law.


President:

Aleksandra Twardowska-Czerwińska

Mail to commission president

Aleksandra is in frequent contact with the members of the commission by using online communication for meetings.

Key Focus Areas

  • Organizing the scientific program for the coming Amsterdam Congress in 2026.
  • EU IP pharma package.

Aleksandra is in frequent contact with the members of the commission by using online communication for meetings.

Key Focus Areas

  • Organizing the scientific program for the coming Amsterdam Congress in 2026.
  • EU IP pharma package.

Current Work & Projects

  • Preparing sessions for UNION-IP Congress in Amsterdam 2026

Work on the aspect of data exclusivity by remodeling the landscape of regulatory data protection (RPD) and market exclusivity. The aim is to move away from the standard formula "8+2+1" to a more modulated and conditional approach.

  • Preparing sessions for UNION-IP Congress in Amsterdam 2026

Work on the aspect of data exclusivity by remodeling the landscape of regulatory data protection (RPD) and market exclusivity. The aim is to move away from the standard formula "8+2+1" to a more modulated and conditional approach.